Skip to search formSkip to main contentSkip to account menu

HR-756

Known as: HR 756, HR756 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1982
1982
A total of 30 hospitalized patients with upper and lower urinary tract infections were treated with cefotaxime (HR-756) by… 
1982
1982
Fundamental and clinical studies on the perinatal use of cefotaxime (CTX, HR-756), a new cephalosporin antibiotic, were done… 
1981
1981
Twenty adult surgical patients aged between 15 and 83 years (mean:45), 10 of whom had wound infections (one complicated with… 
1980
1980
1980
The in vitro antibacterial activity of HR-756 compared to cefoxitin and cefuroxime. 122 multiresistant clinical isolates… 
1980
1980
SummaryThe pharmacokinetic characteristics of the parenteral cephalosporins cephalothin, cefazolin, cephradine, cefamandole… 
1979
1979
The in vitro activities of LY127935 (LY) were compared with those of other beta-lactam antibiotics. LY was highly active (minimal… 
1979
1979
A total of 434 clinical aerobic gram-negative bacillary isolates were tested against LY127935, a new 1-oxa cephalosporin, and… 
1979
1979
The activity of cefotaxime (HR756), a new semi-synthetic cephalosporin, was compared with the activity of ampicillin… 
1979
1979
Azlocillin, carbenicillin, cefsulodin, mezlocillin, nocardicin A, piperacillin, pirbenicillin, sulbenicillin, and ticarcillin…